Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Z Zhang, X Liu, D Chen, J Yu - Signal transduction and targeted …, 2022 - nature.com
Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …
Neutrophil diversity and plasticity in tumour progression and therapy
Neutrophils play a key role in defence against infection and in the activation and regulation
of innate and adaptive immunity. In cancer, tumour-associated neutrophils (TANs) have …
of innate and adaptive immunity. In cancer, tumour-associated neutrophils (TANs) have …
[PDF][PDF] Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
J Xiong, J He, J Zhu, J Pan, W Liao, H Ye, H Wang… - Molecular cell, 2022 - cell.com
Tumor-infiltrating myeloid cells (TIMs) are crucial cell populations involved in tumor immune
escape, and their functions are regulated by multiple epigenetic mechanisms. The precise …
escape, and their functions are regulated by multiple epigenetic mechanisms. The precise …
[PDF][PDF] Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
The tumor microenvironment (TME) influences cancer progression and therapy response.
Therefore, understanding what regulates the TME immune compartment is vital. Here we …
Therefore, understanding what regulates the TME immune compartment is vital. Here we …
[PDF][PDF] A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Tumor-infiltrating myeloid cells (TIMs) are key regulators in tumor progression, but the
similarity and distinction of their fundamental properties across different tumors remain …
similarity and distinction of their fundamental properties across different tumors remain …
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
W Tang, Z Chen, W Zhang, Y Cheng, B Zhang… - Signal transduction and …, 2020 - nature.com
Sorafenib is a multikinase inhibitor capable of facilitating apoptosis, mitigating angiogenesis
and suppressing tumor cell proliferation. In late-stage hepatocellular carcinoma (HCC) …
and suppressing tumor cell proliferation. In late-stage hepatocellular carcinoma (HCC) …
[HTML][HTML] CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion
G Gunaydin - Frontiers in oncology, 2021 - frontiersin.org
Cancer associated fibroblasts (CAFs) and tumor associated macrophages (TAMs) are
among the most important and abundant players of the tumor microenvironment. CAFs as …
among the most important and abundant players of the tumor microenvironment. CAFs as …
Tumor-associated myeloid cells: diversity and therapeutic targeting
A Mantovani, F Marchesi, S Jaillon… - Cellular & molecular …, 2021 - nature.com
Myeloid cells in tumor tissues constitute a dynamic immune population characterized by a
non-uniform phenotype and diverse functional activities. Both tumor-associated …
non-uniform phenotype and diverse functional activities. Both tumor-associated …
Nanomaterials for diagnosis and treatment of brain cancer: Recent updates
Brain tumors, especially glioblastoma, remain the most aggressive form of all the cancers
because of inefficient diagnosis and profiling. Nanostructures, such as metallic …
because of inefficient diagnosis and profiling. Nanostructures, such as metallic …
Tumor microenvironment mediated spermidine-metal-immunopeptide nanocomplex for boosting ferroptotic immunotherapy of lymphoma
T Nie, H Liu, Z Fang, Y Zheng, R Zhang, X Xu, S Liu… - ACS …, 2023 - ACS Publications
Immunotherapy as an alternative treatment strategy for B-cell lymphoma is undesirable
because of tumor heterogeneity and immune surveillance. Spermidine (SPM), as a regulator …
because of tumor heterogeneity and immune surveillance. Spermidine (SPM), as a regulator …